manag
high
mortal
risk
due
signific
progress
requir
prior
assess
timetoprogress
howev
relat
method
avail
pneumonia
retrospect
enrol
adult
patient
admit
one
hospit
jan
feb
final
followup
date
march
compar
characterist
patient
sever
nonsever
outcom
use
multivari
surviv
analys
assess
risk
progress
sever
condit
total
patient
progress
sever
condit
die
mean
time
hospit
admiss
sever
onset
day
age
bodi
mass
index
bmi
fever
symptom
admiss
coexist
hypertens
diabet
associ
sever
progress
compar
nonsever
group
sever
group
alreadi
demonstr
earli
stage
abnorm
biomark
indic
organ
function
inflammatori
respons
blood
oxygen
coagul
function
cohort
character
increas
cumul
incid
sever
progress
day
admiss
compet
risk
surviv
model
incorpor
ct
imag
baselin
inform
show
improv
perform
predict
sever
onset
mean
timedepend
auc
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
sinc
first
report
wuhan
china
decemb
outbreak
quickli
becam
global
public
health
issu
total
infect
death
countri
affect
mar
world
health
organ
one
main
challeng
face
medic
care
lack
effect
tool
select
patient
pose
high
risk
mortal
earli
stage
previou
studi
explor
risk
factor
associ
sever
level
pneumonia
exampl
zhou
etal
identifi
older
age
high
level
ddimer
associ
inhospit
death
shi
etal
found
manifest
chest
ct
imag
abnorm
correl
diseas
state
howev
joint
analysi
time
progress
event
well
integr
multipl
type
input
data
risk
predict
thoroughli
investig
studi
report
retrospect
collect
cohort
character
larg
proport
import
case
use
cohort
data
develop
compet
risk
surviv
model
predict
realtim
risk
progress
sever
condit
upon
hospit
admiss
patient
detail
method
use
studi
found
supplementari
method
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
adult
patient
enrol
studi
treat
shenzhen
third
peopl
hospit
design
hospit
patient
shenzhen
citi
china
typic
diseas
process
patient
illustr
figur
supplementari
appendix
hospit
admiss
one
either
progress
sever
condit
recov
pneumonia
without
sever
progress
among
patient
experienc
sever
progress
critic
condit
mar
patient
die
remain
hospit
other
discharg
hospit
recov
health
statu
mean
durat
symptom
onset
hospit
admiss
day
admiss
sever
onset
day
tabl
supplementari
appendix
evalu
progressionrel
featur
classifi
patient
sever
nonsever
group
base
sever
experi
time
interv
symptom
onset
admiss
significantli
differ
among
two
group
p
summari
statist
shown
tabl
supplementari
appendix
patient
age
bimod
distribut
one
mode
locat
around
year
anoth
year
figur
mean
age
sever
group
significantli
higher
nonsever
group
versu
moreov
sever
group
appear
overweigh
compar
nonsever
group
figur
major
patient
travel
histori
wuhan
region
epicent
initi
outbreak
within
day
symptom
onset
gender
strong
associ
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
blood
type
associ
sever
outcom
either
diseas
histori
significantli
enrich
sever
group
coexist
hypertens
diabet
signific
common
symptom
admiss
fever
cough
fatigu
sore
throat
muscl
ach
diarrhea
sever
group
significantli
higher
rate
present
fever
fatigu
compar
nonsever
group
test
perform
blood
sampl
collect
immedi
hospit
admiss
associ
sever
classif
summar
tabl
supplementari
appendix
sever
group
significantli
lower
number
platelet
lymphocyt
increas
level
coagul
function
indic
fibrinogen
ddimer
activ
partial
thromboplastin
time
blood
biochemistri
biomark
significantli
increas
level
sever
group
compar
nonsever
group
includ
lactat
dehydrogenas
myoglobin
aspart
transaminas
mitochondrialaspart
transaminas
creatin
kinas
myocardi
band
troponin
ntermin
brain
natriuret
peptid
glutamyl
transpeptidas
alphahydroxybutyr
dehydrogenas
decreas
level
includ
albumin
prealbumin
infectionrel
biomark
observ
signific
increas
creactiv
protein
procalcitonin
erythrocyt
sediment
rate
sever
group
mean
level
beyond
upper
bound
normal
refer
also
observ
abnorm
level
blood
oxygen
like
ratio
kidney
function
indic
includ
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
glomerular
filtrat
rate
cystatin
c
lactic
acid
test
earli
stage
associ
sever
outcom
investig
pattern
dynam
variat
cell
plot
cell
count
time
sinc
symptom
onset
stratifi
sever
classif
figur
sever
group
decreas
number
cell
first
day
symptom
onset
number
increas
next
day
plateau
also
observ
level
creactiv
protein
tend
converg
late
stage
hospit
two
group
figur
assess
risk
pattern
diseas
progress
hospit
perform
compet
risk
analysi
timetoev
data
cumul
probabl
aka
cumul
incid
function
sever
onset
continu
increas
immedi
hospit
admiss
arriv
chang
point
day
figur
contrast
cumul
incid
compet
risk
event
discharg
recoveri
much
smaller
high
risk
period
sever
onset
howev
incid
dramat
increas
around
day
person
timedepend
risk
assess
sever
progress
incorpor
ct
imag
data
baselin
inform
risk
model
figur
total
quantit
featur
extract
reconstruct
chest
ct
scan
imag
gener
upon
admiss
cluster
analysi
show
exist
subset
featur
distinguish
sever
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
nonsever
group
figur
comput
featur
earliest
ct
scan
admiss
patient
train
risk
predict
score
use
highdimension
surviv
model
model
integr
ct
baselin
variabl
significantli
outperform
univari
model
multivari
model
use
baselin
inform
figur
best
model
achiev
mean
timedepend
auc
mean
predict
error
also
develop
model
integr
laboratori
biomark
test
time
within
one
day
admiss
model
mean
auc
mean
predict
error
figur
supplementari
appendix
present
four
case
studi
exemplifi
usag
ct
imagebas
risk
assess
tool
figur
case
ii
similar
age
bmi
case
unilater
groundglass
opac
ct
imag
case
ii
obvious
bilater
opac
figur
howev
realiti
case
rather
case
ii
progress
sever
condit
consist
model
predict
cumul
probabl
develop
sever
case
within
next
day
compar
case
ii
respect
figur
presenc
fever
symptom
admiss
case
add
discrimin
power
model
anoth
scenario
case
iii
iv
similar
age
bmi
fever
symptom
case
iii
multifoc
groundglass
opac
consolid
figur
case
iii
progress
quickli
within
day
ct
scan
case
iv
sever
progress
accordingli
model
predict
cumul
probabl
develop
sever
case
iii
within
next
day
compar
case
iv
respect
figur
dispar
ct
imag
manifest
contribut
significantli
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
reason
risk
assess
exampl
delin
characterist
retrospect
cohort
adult
patient
collect
singl
center
shenzhen
citi
china
develop
noninvas
method
evalu
risk
progress
sever
condit
independ
predisposit
factor
progress
includ
old
age
high
bmi
fever
coexist
hypertens
diabet
diseas
howev
use
age
singl
prognost
factor
could
lead
erron
result
sinc
young
patient
necessarili
progressionfre
differ
previou
studi
sever
group
cohort
significantli
higher
proport
patient
fever
symptom
admiss
vs
moreov
identifi
first
time
overweight
associ
diseas
sever
find
benefit
risk
assess
analysi
show
model
combin
indic
substanti
improv
predict
perform
compar
model
contain
univari
predictor
mean
timedepend
auc
versu
entri
host
cell
angiotensinconvert
enzym
whose
express
enhanc
usag
hypertens
medicin
ace
inhibitor
angiotensin
ii
typei
receptor
blocker
arb
whether
medic
causal
factor
higher
risk
progress
thu
investig
studi
observ
cooccur
hypertens
disord
significantli
relat
sever
progress
found
associ
medic
sever
outcom
among
hypertens
patient
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
pneumonia
multist
diseas
clinic
relev
intermedi
endpoint
like
sever
onset
surviv
data
analys
set
onset
primari
end
point
censor
recoveri
hospit
discharg
howev
compet
risk
sever
onset
present
analyt
method
induc
bia
studi
risk
sever
progress
assess
without
consid
competit
would
overestim
patient
would
never
progress
discharg
hospit
without
progress
treat
could
progress
extent
bia
adjust
compet
risk
model
evalu
clinic
virolog
oncolog
research
incorpor
highdimension
variabl
select
techniqu
compet
risk
model
quantit
imag
featur
extens
evalu
accord
contribut
risk
predict
evalu
result
show
incorpor
ct
imag
significantli
improv
predict
perform
compar
base
demograph
clinic
inform
mean
timedepend
auc
versu
particular
improv
achiev
one
addit
imag
featur
suggest
import
use
multimod
data
risk
analysi
laboratori
test
result
studi
show
time
admiss
sever
group
patient
alreadi
present
sign
function
impair
organ
liver
eg
lactat
dehydrogenas
prealbumin
heart
eg
multipl
type
myocardi
enzym
includ
troponin
ntermin
brain
natriuret
peptid
creatin
kinas
myocardi
band
mitochondrialaspart
transaminas
aspart
transaminas
kidney
eg
glomerular
filtrat
rate
cystatin
c
signal
abnorm
blood
oxygen
also
emerg
ratio
use
determin
sever
onset
studi
show
signific
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
although
ideal
differ
two
group
upon
admiss
consist
previou
studi
sever
group
cohort
demonstr
earli
stage
substanti
increas
inflammatori
factor
creactiv
protein
dysfunct
coagul
incorpor
laboratori
biomark
test
earli
stage
also
significantli
improv
risk
predict
perform
compar
best
model
without
consid
mean
auc
versu
still
left
possibl
extens
first
laboratori
test
data
integr
ct
imagebas
model
blood
sampl
collect
along
imag
center
complic
statist
model
requir
account
error
caus
time
differ
inher
input
data
second
occurr
sever
may
depend
factor
treatment
viral
load
genet
factor
model
includ
addit
covari
howev
avail
wellprocess
data
factor
scarc
shown
current
model
reason
predict
perform
even
without
consid
third
limit
sampl
size
patient
progress
sever
evalu
model
predict
perform
crossvalid
valid
need
conduct
extern
dataset
fourth
restrict
analysi
sever
group
sever
onset
factor
relat
recoveri
sever
condit
evalu
final
studi
includ
young
patient
age
knowledg
first
attempt
estim
realtim
occurr
risk
sever
cohort
featur
signific
amount
import
case
believ
result
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
studi
help
medic
practition
consid
better
manag
care
pneumonia
patient
upon
admiss
figur
analysi
repres
featur
significantli
associ
sever
group
age
distribut
studi
cohort
overlaid
kernel
densiti
estim
solid
curv
b
boxplot
summari
age
bmi
stratifi
sever
nonsever
group
c
level
individu
laboratori
biomark
plot
along
time
symptom
onset
data
day
multipl
patient
collaps
togeth
median
valu
solid
dot
shown
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
figur
cumul
probabl
develop
sever
condit
discharg
hospit
hospit
admiss
studi
cohort
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
